Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV
Cognitive impairment remains frequent and heterogeneous in presentation and severity among virally suppressed (VS) women with HIV (WWH). We identified cognitive profiles among 929 VS-WWH and 717 HIV-uninfected women from 11 Women's Interagency HIV Study sites at their first neuropsychological (...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.604984/full |
id |
doaj-838402b711b6400a97c8f66affa763ff |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Raha M. Dastgheyb Alison S. Buchholz Kathryn C. Fitzgerald Yanxun Xu Yanxun Xu Dionna W. Williams Dionna W. Williams Gayle Springer Kathryn Anastos Deborah R. Gustafson Amanda B. Spence Adaora A. Adimora Drenna Waldrop David E. Vance Joel Milam Hector Bolivar Kathleen M. Weber Norman J. Haughey Norman J. Haughey Pauline M. Maki Leah H. Rubin Leah H. Rubin Leah H. Rubin |
spellingShingle |
Raha M. Dastgheyb Alison S. Buchholz Kathryn C. Fitzgerald Yanxun Xu Yanxun Xu Dionna W. Williams Dionna W. Williams Gayle Springer Kathryn Anastos Deborah R. Gustafson Amanda B. Spence Adaora A. Adimora Drenna Waldrop David E. Vance Joel Milam Hector Bolivar Kathleen M. Weber Norman J. Haughey Norman J. Haughey Pauline M. Maki Leah H. Rubin Leah H. Rubin Leah H. Rubin Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV Frontiers in Neurology HIV cognition women heterogeneity phenotypes random forest |
author_facet |
Raha M. Dastgheyb Alison S. Buchholz Kathryn C. Fitzgerald Yanxun Xu Yanxun Xu Dionna W. Williams Dionna W. Williams Gayle Springer Kathryn Anastos Deborah R. Gustafson Amanda B. Spence Adaora A. Adimora Drenna Waldrop David E. Vance Joel Milam Hector Bolivar Kathleen M. Weber Norman J. Haughey Norman J. Haughey Pauline M. Maki Leah H. Rubin Leah H. Rubin Leah H. Rubin |
author_sort |
Raha M. Dastgheyb |
title |
Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV |
title_short |
Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV |
title_full |
Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV |
title_fullStr |
Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV |
title_full_unstemmed |
Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV |
title_sort |
patterns and predictors of cognitive function among virally suppressed women with hiv |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2021-02-01 |
description |
Cognitive impairment remains frequent and heterogeneous in presentation and severity among virally suppressed (VS) women with HIV (WWH). We identified cognitive profiles among 929 VS-WWH and 717 HIV-uninfected women from 11 Women's Interagency HIV Study sites at their first neuropsychological (NP) test battery completion comprised of: Hopkins Verbal Learning Test-Revised, Trail Making, Symbol Digit Modalities, Grooved Pegboard, Stroop, Letter/Animal Fluency, and Letter-Number Sequencing. Using 17 NP performance metrics (T-scores), we used Kohonen self-organizing maps to identify patterns of high-dimensional data by mapping participants to similar nodes based on T-scores and clustering those nodes. Among VS-WWH, nine clusters were identified (entropy = 0.990) with four having average T-scores ≥45 for all metrics and thus combined into an “unimpaired” profile (n = 311). Impaired profiles consisted of weaknesses in: (1) sequencing (Profile-1; n = 129), (2) speed (Profile-2; n = 144), (3) learning + recognition (Profile-3; n = 137), (4) learning + memory (Profile-4; n = 86), and (5) learning + processing speed + attention + executive function (Profile-5; n = 122). Sociodemographic, behavioral, and clinical variables differentiated profile membership using Random Forest models. The top 10 variables distinguishing the combined impaired vs. unimpaired profiles were: clinic site, age, education, race, illicit substance use, current and nadir CD4 count, duration of effective antiretrovirals, and protease inhibitor use. Additional variables differentiating each impaired from unimpaired profile included: depression, stress-symptoms, income (Profile-1); depression, employment (Profile 2); depression, integrase inhibitor (INSTI) use (Profile-3); employment, INSTI use, income, atazanavir use, non-ART medications with anticholinergic properties (Profile-4); and marijuana use (Profile-5). Findings highlight consideration of NP profile heterogeneity and potential modifiable factors contributing to impaired profiles. |
topic |
HIV cognition women heterogeneity phenotypes random forest |
url |
https://www.frontiersin.org/articles/10.3389/fneur.2021.604984/full |
work_keys_str_mv |
AT rahamdastgheyb patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT alisonsbuchholz patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT kathryncfitzgerald patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT yanxunxu patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT yanxunxu patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT dionnawwilliams patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT dionnawwilliams patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT gaylespringer patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT kathrynanastos patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT deborahrgustafson patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT amandabspence patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT adaoraaadimora patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT drennawaldrop patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT davidevance patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT joelmilam patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT hectorbolivar patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT kathleenmweber patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT normanjhaughey patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT normanjhaughey patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT paulinemmaki patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT leahhrubin patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT leahhrubin patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv AT leahhrubin patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv |
_version_ |
1724274499242688512 |
spelling |
doaj-838402b711b6400a97c8f66affa763ff2021-02-11T06:01:55ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-02-011210.3389/fneur.2021.604984604984Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIVRaha M. Dastgheyb0Alison S. Buchholz1Kathryn C. Fitzgerald2Yanxun Xu3Yanxun Xu4Dionna W. Williams5Dionna W. Williams6Gayle Springer7Kathryn Anastos8Deborah R. Gustafson9Amanda B. Spence10Adaora A. Adimora11Drenna Waldrop12David E. Vance13Joel Milam14Hector Bolivar15Kathleen M. Weber16Norman J. Haughey17Norman J. Haughey18Pauline M. Maki19Leah H. Rubin20Leah H. Rubin21Leah H. Rubin22Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, United StatesDivision of Biostatistics and Bioinformatics, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDivision of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United StatesMontefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United StatesDepartment of Neurology, State University of New York Downstate Health Sciences University, Brooklyn, NY, United States0Division of Infectious Disease and Travel Medicine, Department of Medicine, Georgetown University, Washington, DC, United States1Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States2Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, United States3School of Nursing, University of Alabama at Birmingham, Birmingham, AL, United States4Institute for Health Promotion & Disease Prevention Research, University of Southern California, Los Angeles, CA, United States5Department of Psychiatry & Behavioral Science, University of Miami Miller School of Medicine, Miami, FL, United States6CORE Center, Cook County Health, Hektoen Institute of Medicine, Chicago, IL, United StatesDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States7Department of Psychiatry and Psychology, University of Illinois at Chicago, Chicago, IL, United StatesDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United StatesCognitive impairment remains frequent and heterogeneous in presentation and severity among virally suppressed (VS) women with HIV (WWH). We identified cognitive profiles among 929 VS-WWH and 717 HIV-uninfected women from 11 Women's Interagency HIV Study sites at their first neuropsychological (NP) test battery completion comprised of: Hopkins Verbal Learning Test-Revised, Trail Making, Symbol Digit Modalities, Grooved Pegboard, Stroop, Letter/Animal Fluency, and Letter-Number Sequencing. Using 17 NP performance metrics (T-scores), we used Kohonen self-organizing maps to identify patterns of high-dimensional data by mapping participants to similar nodes based on T-scores and clustering those nodes. Among VS-WWH, nine clusters were identified (entropy = 0.990) with four having average T-scores ≥45 for all metrics and thus combined into an “unimpaired” profile (n = 311). Impaired profiles consisted of weaknesses in: (1) sequencing (Profile-1; n = 129), (2) speed (Profile-2; n = 144), (3) learning + recognition (Profile-3; n = 137), (4) learning + memory (Profile-4; n = 86), and (5) learning + processing speed + attention + executive function (Profile-5; n = 122). Sociodemographic, behavioral, and clinical variables differentiated profile membership using Random Forest models. The top 10 variables distinguishing the combined impaired vs. unimpaired profiles were: clinic site, age, education, race, illicit substance use, current and nadir CD4 count, duration of effective antiretrovirals, and protease inhibitor use. Additional variables differentiating each impaired from unimpaired profile included: depression, stress-symptoms, income (Profile-1); depression, employment (Profile 2); depression, integrase inhibitor (INSTI) use (Profile-3); employment, INSTI use, income, atazanavir use, non-ART medications with anticholinergic properties (Profile-4); and marijuana use (Profile-5). Findings highlight consideration of NP profile heterogeneity and potential modifiable factors contributing to impaired profiles.https://www.frontiersin.org/articles/10.3389/fneur.2021.604984/fullHIVcognitionwomenheterogeneityphenotypesrandom forest |